Literature DB >> 29951925

[Target volume concepts in radiotherapy and their implications for imaging].

N G Burnet1, D J Noble2, A Paul3, G A Whitfield4, S Delorme5,6.   

Abstract

CLINICAL ISSUE: Successful radiotherapy requires precise localization of the tumor and requires high-quality imaging for developing a treatment plan. STANDARD TREATMENT: Irradiation of the tumor region, including a safety margin. TREATMENT INNOVATIONS: The target volume consists of the gross tumor volume (GTV) containing visible parts of the tumor, the clinical target volume (CTV) covering the GTV plus invisible tumor extensions, and the planning target volume (PTV) to account for uncertainties. The non-GTV parts of the CTV are based on historical patient data. The PTV margins are based on a calculation of possible uncertainties during planning, setup, or treatment. Normal tissue deserves the identical care in contouring, since its tolerance may limit the tumor dose, taking into account the contours of organs at risk. Serial risk organs benefit from defining a planning organ of risk volume (PRV) to better limit the dose delivered to them. DIAGNOSTIC WORK-UP: The better the imaging, the more reliable the definition of the GTV and treatment success will be. Multiple imaging sequences are desirable to support the delineation of the tumor. They may result in different CTVs that, depending on their tumor burden, may require different doses. PERFORMANCE: The definition of standardized target volumes according to the ICRU reports 50, 62, and 83 forms the basis for an individualized radiation treatment planning according to unified criteria on a high-quality level. ACHIEVEMENTS: Radio-oncology is by nature interdisciplinary, the diagnostic radiologist being an indispensable team partner. A regular dialogue between the disciplines is pivotal for target volume definition and treatment success. PRACTICAL RECOMMENDATIONS: Imaging for target volume definition requires highest quality imaging, the use of functional imaging methods and close cooperation with a diagnostic radiologist experienced in this field.

Entities:  

Keywords:  Computed tomography; Magnetic resonance imaging; Positron emission tomography; Radiotherapy; Target volume definition

Mesh:

Year:  2018        PMID: 29951925     DOI: 10.1007/s00117-018-0420-6

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  27 in total

Review 1.  Identifying patients who may benefit from adaptive radiotherapy: Does the literature on anatomic and dosimetric changes in head and neck organs at risk during radiotherapy provide information to help?

Authors:  Charlotte L Brouwer; Roel J H M Steenbakkers; Johannes A Langendijk; Nanna M Sijtsema
Journal:  Radiother Oncol       Date:  2015-06-17       Impact factor: 6.280

Review 2.  Image-guided radiotherapy: from current concept to future perspectives.

Authors:  David A Jaffray
Journal:  Nat Rev Clin Oncol       Date:  2012-11-20       Impact factor: 66.675

Review 3.  Advances in radiotherapy.

Authors:  Saif S Ahmad; Simon Duke; Rajesh Jena; Michael V Williams; Neil G Burnet
Journal:  BMJ       Date:  2012-12-04

4.  Fast imaging employing steady-state acquisition (FIESTA) MRI to investigate cerebrospinal fluid (CSF) within dural reflections of posterior fossa cranial nerves.

Authors:  David J Noble; Daniel Scoffings; Thankamma Ajithkumar; Michael V Williams; Sarah J Jefferies
Journal:  Br J Radiol       Date:  2016-09-29       Impact factor: 3.039

5.  Impact of coronal and sagittal views on lung gross tumor volume delineation.

Authors:  Isabelle Fitton; Joop C Duppen; Roel J H M Steenbakkers; Heidi Lotz; Peter J C M Nowak; Coen R N Rasch; Marcel van Herk
Journal:  Phys Med       Date:  2016-09-03       Impact factor: 2.685

Review 6.  Imaging and target volume delineation in glioma.

Authors:  G A Whitfield; S R Kennedy; I K Djoukhadar; A Jackson
Journal:  Clin Oncol (R Coll Radiol)       Date:  2014-05-11       Impact factor: 4.126

7.  NIMRAD - a phase III trial to investigate the use of nimorazole hypoxia modification with intensity-modulated radiotherapy in head and neck cancer.

Authors:  D Thomson; H Yang; H Baines; E Miles; S Bolton; C West; N Slevin
Journal:  Clin Oncol (R Coll Radiol)       Date:  2014-03-28       Impact factor: 4.126

Review 8.  Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets.

Authors:  Tomas Skripcak; Claus Belka; Walter Bosch; Carsten Brink; Thomas Brunner; Volker Budach; Daniel Büttner; Jürgen Debus; Andre Dekker; Cai Grau; Sarah Gulliford; Coen Hurkmans; Uwe Just; Mechthild Krause; Philippe Lambin; Johannes A Langendijk; Rolf Lewensohn; Armin Lühr; Philippe Maingon; Michele Masucci; Maximilian Niyazi; Philip Poortmans; Monique Simon; Heinz Schmidberger; Emiliano Spezi; Martin Stuschke; Vincenzo Valentini; Marcel Verheij; Gillian Whitfield; Björn Zackrisson; Daniel Zips; Michael Baumann
Journal:  Radiother Oncol       Date:  2014-10-28       Impact factor: 6.280

9.  Delivered dose can be a better predictor of rectal toxicity than planned dose in prostate radiotherapy.

Authors:  L E A Shelley; J E Scaife; M Romanchikova; K Harrison; J R Forman; A M Bates; D J Noble; R Jena; M A Parker; M P F Sutcliffe; S J Thomas; N G Burnet
Journal:  Radiother Oncol       Date:  2017-04-28       Impact factor: 6.280

10.  The future of image-guided radiotherapy-is image everything?

Authors:  David J Noble; Neil G Burnet
Journal:  Br J Radiol       Date:  2018-05-17       Impact factor: 3.039

View more
  1 in total

Review 1.  Precision Radiotherapy: 18F-FDG PET-based radiotherapy planning in Head and Neck cancers.

Authors:  Padma Subramanyam; Shanmuga Sundaram Palaniswamy; Shah Pervez Numani
Journal:  World J Nucl Med       Date:  2020-08-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.